Skip to content
Screener

Milestone Pharmaceuticals MIST Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$238.0KMiss by $29.9M
EPS-$0.20Miss by $0.26
Revenue estimate$30.1M
EPS estimate$0.06

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$1.1M
EPS estimate-$0.20

FAQ

When did Milestone Pharmaceuticals report Q1 2026 earnings?
Milestone Pharmaceuticals (MIST) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Milestone Pharmaceuticals's Q1 2026 revenue and EPS?
Milestone Pharmaceuticals reported revenue of $238.0K and eps of $-0.20 for Q1 2026.
Did Milestone Pharmaceuticals beat estimates in Q1 2026?
Revenue missed the consensus estimate of $30.1M by $29.9M. EPS missed the consensus estimate of $0.06 by $0.26.
How did Milestone Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 35.5% from $-0.31.
Where can I find Milestone Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-059780) and the 10-Q periodic report (0001104659-26-059752) directly on SEC EDGAR. The filing index links above go to sec.gov.